The European Chemicals Agency (ECHA), following a proposal submitted by France, has recommended classifying cannabidiol (CBD) as a Category 1B reproductive toxicant under the EU Classification, Labelling and Packaging (CLP) Regulation. This classification means CBD is presumed to pose risks to human reproduction based primarily on animal research, including potential damage to fertility, harm to unborn children, and risks to breastfed infants. Lex Pelger dove into the evidence and concluded that the growing body of research warrants concern and that future regulations should be sensible and science-driven.
Laboratory research involving human sperm and testicular cells suggests that CBD may interfere with sperm movement and damage Sertoli cells, which support sperm development. Regarding lactation, studies have detected CBD in human breast milk, while animal research suggests that CBD can alter milk composition, reduce lipid and protein levels, and affect milk-producing cells. However, Mr. Pelger acknowledges that there is very limited research involving humans who take CBD supplements specifically while breastfeeding.
Lex Pelger contends that CBD should not automatically be considered safe simply because it is non-intoxicating or derived from hemp. For pregnant individuals, the recommendation is to avoid CBD when it is not medically necessary, while recognizing that someone relying on it for significant symptoms may need to weigh potential risks against the benefits with appropriate medical guidance. For men attempting to conceive, Pelger recommends discontinuing CBD and THC, particularly when fertility difficulties are present. Check out the embedded video below for Pelger’s full analysis via his YouTube channel:
Sponsored Content
This informative article is brought to you by NUBO CBD →